Abstract:Objective To investigate the effect of flurbiprofcn axetil combined with lung-protective ventilation on postoperative cellular immune function in the patients undergoing thoracoscopic radical resection of lung cancer.Methods Eighty American Society of Anesthesiologists physical status Ⅰ or Ⅱ patients of both sexes,with no abnormal lung function during the preoperative examination,aged 35-64 yr,with body mass index of 18-28 kg/m2,scheduled for elective thoracoscopic radical resection of lung cancer under general anesthesia,were divided into 4 groups (n =20 each) using a random number table method:conventional mechanical ventilation group (group C),flurbiprofen axetil combined with conventional mechanical ventilation group (group F+C),lung-protective ventilation group (group P) and flurbiprofen axetil combined with lung-protective ventilation group (group F+P).Flurbiprofen axetil 2 mg/kg was intravenously injected at 5 min before induction of anaesthesia in F+C and F+P groups.Patients were mechanically ventilated in volume-controlled mode in four groups.Conventional ventilator settings were adjusted with tidal volume (VT) 10 ml/kg and respiratory rate 10-20 breaths/min during two-lung ventilation and with VT 8 ml/kg and respiratory rate 13-16 breaths/min during one-lung ventilation.Lung-protective ventilator settings were adjusted with VT 8 ml/kg and respiratory rate 12-14 breaths/min during two-lung ventilation and with positive end-expiratory pressure 5 cmH2O,VT 6 ml/kg and respiratory rate 14-16 breaths/min during onelung ventilation.All patients received patient-controlled intravenous analgesia (PCIA) at the end of surgery until 24 h after surgery.PCIA solution contained sufentanil 100 μg and ondansetron 16 mg in 100 ml of normal saline in group C and group P.PCIA solution contained sufentanil 100 μg,flurbiprofen axetil 2 mg/kg and ondansetron 16 mg in 100 ml of normal saline in group F+C and group F+P.The PCIA pump was set up with a 0.5 ml bolus dose,a 15-min lockout interval and background infusion at a rate of 2 ml/h.Visual analog scale score was maintained ≤3.When visual analog scale score ＞3,tramadol 2 mg/kg was intravenously injected.Before induction of anesthesia (T0),at the end of surgery (T1),at 24 and 72 h after surgery (T2,3) and at 1 week after surgery (T4),blood samples were collected from the central vein for measurement of the levels of T lymphocyte subsets CD3+,CD4+,CD8+ and NK cells.The CD4+/CD8+ ratio was calculated.Results Compared with the baseline at T0,the levels of CD3+,CD4+ and NK cells and CD4+/CD8+ratio were significantly decreased at T1-3 in C,F+C and P groups and at T1,2 in group F+P (P＜0.05).Compared with group C,the levels of CD3+,CD4+ and NK cells and CD4+/CD8+ratio were significantly increased at T1-3 in the other three groups (P＜0.05).Compared with group F+C or group P,the levels of CD3+,CD4+ and NK cells and CD4+/CD8+ratio were significantly increased at T1-3 in group F+ P (P＜0.05).Conclusion Flurbiprofen axetil combined with lung-protective ventilation improves postoperative cellular immune function and provides better efficacy than either alone in the patients undergoing thoracoscopic radical resection of lung cancer.

Effects of postoperative analgesia with flurbiprofen axetil combined with morphine on T-lymphocyte subsets and natural killer cells in patients undertaken gastric cancer surgery

Preemptive analgesia effects of flurbiprofen axetil in patients divesting tonsils

Flurbiprofen Improves Dysfunction of T-lymphocyte Subsets and Natural Killer Cells in Cancer Patients Receiving Post-Operative Morphine Analgesia.

The Effect of Lipid Microspheres Flurbiprofen Axetil Injection on the Expression of Inflammatory Cytokines in Patients Undergoing Gastroenteral Cancer Transection Surgery

[Effects of Preemptive Analgesia with Flurbiprofen on the Blood Sugar and Interleukin-6 of Patients after Radical Excision of Breast Cancer].

[Effect of Postoperative Analgesia with Flurbiprofen Axetil and Sufentanyl on Metabolism of Surgical Patients with Intestinal Carcinoma].

Observation for flurbiprofen axetil combined with low dose morphine using on intravenous postoperative analgesia after thoracic surgery

Effect of perioperative intravenous flurbiprofen axetil on chronic postmastectomy pain.

Effect of Flurbiprofen Axetil Combined with Lung-Protective Ventilation on Postoperative Cellular Immune Function in Patients Undergoing Thoracoscopic Radical Resection of Lung Cancer

Effects of Oxycodone Combined With Flurbiprofen Axetil on Postoperative Analgesia and Immune Function in Patients Undergoing Radical Resection of Colorectal Cancer

Effect of flurbiprofen axetil on postoperative inflammatory factors and stress hormonein patients undergoing laparoscopic radical rectectomy for rectal cancer

The influence of anesthesia and means of postoperative pain control on T lymphocyte subtypes of blood in patients with rectal cancer

Effects of parecoxib sodium and fentanyl multimodal analgesia on immune functions in patients undergoing hepatectomy for hepatocellular carcinoma

Effects of PCIA with Nalbuphine on Postoperative Cellular Immune Function in Patients Undergoing Liver Cancer Resection

Effects of Lornoxicam or Morphine PCIA on Plasma Levels of TNF-α and IL-10 in the Patients with Cancer

Administration of flurbiprofen axetil and dezocine for the postoperative analgesia in patients with non‐small cell lung cancer: A randomized, controlled study

The effects of epidural anaesthesia and analgesia on T lymphocytes differentiation markers and cytokines in patients after gastric cancer resection

Analgesic effect of flurbiprofen axetil used at different time points after thoracic surgery

Effect of Postoperative Patient-Controlled Analgesia by Different Administration Routes on T-lymphocyte Subtypes and Natural Killer Cells of Blood in Patients with Esophageal Carcinoma

Effect of Flurbiprofen Axetil for Postoperative Patient-Controlled Intravenous Analgesia in Patients Underwent Laparoscopic Surgery in Treating Women Diseases

Clinical Observation of Flurbiprofen Axetil on Preemptive Analgesia During Radical Operation of Mastocarcinoma